Does DAROLUTAMIDE Cause Prostate cancer? 101 Reports in FDA Database
Prostate Health & Male Vitality — Naturally
ProstaVive: better flow, better sleep, better energy. 180-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 101 reports of Prostate cancer have been filed in association with DAROLUTAMIDE (NUBEQA). This represents 3.1% of all adverse event reports for DAROLUTAMIDE.
101
Reports of Prostate cancer with DAROLUTAMIDE
3.1%
of all DAROLUTAMIDE reports
25
Deaths
18
Hospitalizations
How Dangerous Is Prostate cancer From DAROLUTAMIDE?
Of the 101 reports, 25 (24.8%) resulted in death, 18 (17.8%) required hospitalization, and 2 (2.0%) were considered life-threatening.
Is Prostate cancer Listed in the Official Label?
Yes, Prostate cancer is listed as a known adverse reaction in the official FDA drug label for DAROLUTAMIDE.
What Other Side Effects Does DAROLUTAMIDE Cause?
Fatigue (384)
Death (361)
Hot flush (203)
Asthenia (173)
Prostatic specific antigen increased (156)
Off label use (133)
Neuropathy peripheral (127)
Diarrhoea (122)
Dizziness (122)
Rash (116)
What Other Drugs Cause Prostate cancer?
RANITIDINE (60,641)
LEUPROLIDE (1,736)
ABIRATERONE (661)
ENZALUTAMIDE (642)
ADALIMUMAB (573)
ETANERCEPT (482)
METHOTREXATE (444)
INFLIXIMAB (376)
LENALIDOMIDE (366)
PREDNISONE (317)
Which DAROLUTAMIDE Alternatives Have Lower Prostate cancer Risk?
DAROLUTAMIDE vs DARUNAVIR
DAROLUTAMIDE vs DARUNAVIR ETHANOLATE
DAROLUTAMIDE vs DARUNAVIR\RITONAVIR
DAROLUTAMIDE vs DASABUVIR
DAROLUTAMIDE vs DASABUVIR\OMBITASVIR HEMINONAHYDRATE\PARITAPREVIR\RITONAVIR